Literature DB >> 32127666

Therapeutic options for the 2019 novel coronavirus (2019-nCoV).

Guangdi Li, Erik De Clercq.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32127666     DOI: 10.1038/d41573-020-00016-0

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 2.  Coronaviruses - drug discovery and therapeutic options.

Authors:  Alimuddin Zumla; Jasper F W Chan; Esam I Azhar; David S C Hui; Kwok-Yung Yuen
Journal:  Nat Rev Drug Discov       Date:  2016-02-12       Impact factor: 84.694

Review 3.  New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections.

Authors:  Erik De Clercq
Journal:  Chem Asian J       Date:  2019-08-07
  3 in total
  498 in total

1.  Novel Development of Predictive Feature Fingerprints to Identify Chemistry-Based Features for the Effective Drug Design of SARS-CoV-2 Target Antagonists and Inhibitors Using Machine Learning.

Authors:  Kelvin Cooper; Christopher Baddeley; Bernie French; Katherine Gibson; James Golden; Thiam Lee; Sadrach Pierre; Brent Weiss; Jason Yang
Journal:  ACS Omega       Date:  2021-02-05

2.  Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease.

Authors:  Rachel M Golonka; Piu Saha; Beng San Yeoh; Saurabh Chattopadhyay; Andrew T Gewirtz; Bina Joe; Matam Vijay-Kumar
Journal:  Physiol Genomics       Date:  2020-04-10       Impact factor: 3.107

3.  Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.

Authors:  Anil R Maharaj; Huali Wu; Christoph P Hornik; Stephen J Balevic; Chi D Hornik; P Brian Smith; Daniel Gonzalez; Kanecia O Zimmerman; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  JAMA Pediatr       Date:  2020-10-05       Impact factor: 16.193

4.  Generalized Z-numbers with hesitant fuzzy linguistic information and its application to medicine selection for the patients with mild symptoms of the COVID-19.

Authors:  Zongyuan Ren; Huchang Liao; Yuxi Liu
Journal:  Comput Ind Eng       Date:  2020-05-01       Impact factor: 5.431

5.  Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.

Authors:  Ke Hu; Wei-Jie Guan; Ying Bi; Wei Zhang; Lanjuan Li; Boli Zhang; Qingquan Liu; Yuanlin Song; Xingwang Li; Zhongping Duan; Qingshan Zheng; Zifeng Yang; Jingyi Liang; Mingfeng Han; Lianguo Ruan; Chaomin Wu; Yunting Zhang; Zhen-Hua Jia; Nan-Shan Zhong
Journal:  Phytomedicine       Date:  2020-05-16       Impact factor: 5.340

6.  Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

Authors:  Anuruddha Abeygunasekera; Saroj Jayasinghe
Journal:  Med Hypotheses       Date:  2020-05-18       Impact factor: 1.538

Review 7.  Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review.

Authors:  Elnaz Khani; Sajad Khiali; Taher Entezari-Maleki
Journal:  J Clin Pharmacol       Date:  2021-03-05       Impact factor: 3.126

8.  Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.

Authors:  Carina Conzelmann; Janis A Müller; Lukas Perkhofer; Konstantin Mj Sparrer; Alexander N Zelikin; Jan Münch; Alexander Kleger
Journal:  Clin Med (Lond)       Date:  2020-08-30       Impact factor: 2.659

Review 9.  Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19.

Authors:  Mark Laws; Yasmin M Surani; Md Mahbub Hasan; Yiyuan Chen; Peiqin Jin; Taha Al-Adhami; Madiha Chowdhury; Aqeel Imran; Ioannis Psaltis; Shirin Jamshidi; Kazi S Nahar; Khondaker Miraz Rahman
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530

10.  Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.

Authors:  Tianguang Huang; Lin Sun; Dongwei Kang; Vasanthanathan Poongavanam; Xinyong Liu; Peng Zhan; Luis Menéndez-Arias
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.